Potential triggers of MS

Results and Problems in Cell Differentiation

Volumn 51, Issue , 2010, Pages 21-42

  Libbey, Jane E ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; CARDIOVIRUS INFECTION; DISEASE MODEL; DNA VIRUS INFECTION; EPSTEIN BARR VIRUS; HUMAN; HUMAN HERPESVIRUS 6; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; PATHOGENICITY; TORQUE TENO VIRUS; VIROLOGY; CARDIOVIRUS INFECTIONS; DNA VIRUS INFECTIONS; TORQUE TENO VIRUS 1;

ANIMALS; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; DNA VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; MICE; MULTIPLE SCLEROSIS; THEILOVIRUS; TORQUE TENO VIRUS;

EID: 77956938380     PISSN: 00801844     EISSN: 18610412     Source Type: Book Series    
DOI: 10.1007/400_2008_12     Document Type: Article

References (104)

1. Álvarez-Lafuente R, de Las Hervas V, Bartolome M, Picazo JJ, Arroyo R (2004) Relapsingremitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol 61:1523-1527
2. Álvarez-Lafuente R, de Las Hervas V, Garcia-Montojo M, Bartolome M, Arroyo R (2007) Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive. Mult Scler 13:578-583
3. Álvarez-Lafuente R, Garcia-Montojo M, de Las Hervas V, Bartolome M, Arroyo R (2006) Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients. J Clin Virol 37(Suppl 1):S24-S26
4. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A (1993) Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 240:417-422
5. Ascherio A, Munch M (2000) Epstein-Barr virus and multiple sclerosis. Epidemiology 11:220-224
6. Ascherio A, Munger KL (2007a) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61:288-299
7. Ascherio A, Munger KL (2007b) Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61:504-513
8. Asher DM (1991) Slow viral infections of the human nervous system. In: Scheld WM, Whitley RJ, Durack DT (eds) Infections of the central nervous system. Raven, New York, pp 145-166
9. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000) Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393-404
10. Barnett LA, Fujinami RS (1992) Molecular mimicry: a mechanism for autoimmune injury. FASEB J 6:840-844
11. Barnett LA, Whitton JL, Wada Y, Fujinami RS (1993) Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein [published erratum appears in J. Neuroimmunol. 48:120, 1993].
12. J Neuroimmunol 44:15-25
13. Barnett LA, Whitton JL, Wang LY, Fujinami RS (1996) Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J Neuroimmunol 64:163-173
14. Berti R, Brennan MB, Soldan SS, Ohayon JM, Casareto L, McFarland HF, Jacobson S (2002) Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J NeuroVirol 8:250-256
15. Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165-171
16. Brahic M, Bureau JF, Michiels T (2005) The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol 59:279-298
17. Buljevac D, Flach HZ, Hop WCJ, Hijdra D, Laman JD, Savelkoul HFJ, van der Meché FGA, Van Doorn PA, Hintzen RQ (2002) Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125:952-960
18. Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, Van Doorn PA, van der Meché FGA, Hintzen RQ (2005) Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatr 76:1377-1381
19. Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Bussow K, Sommer N, Hemmer B (2005) Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115:1352-1360
20. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92:7440-7444
21. Christensen T (2007) Human herpesviruses in MS. Int MS J 14:41-47
22. Cirone M, Cuomo L, Zompetta C, Ruggieri S, Frati L, Faggioni A, Ragona G (2002) Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens. J Med Virol 68:268-272
23. Coo H, Aronson KJ (2004) A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology 23:1-12
24. Correale J, Fiol M, Gilmore W (2006) The risk of relapses in multiple sclerosis during systemic infections. Neurology 67:652-659
25. De Keyser J, Zwanikken C, Boon M (1998) Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 159:51-53
26. Derfuss T, Hohlfeld R, Meinl E (2005) Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol 252:968-971
27. Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68:S22-S31
28. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD (1998) Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatr 64:736-741
29. Evans BK, Donely DK, Whitaker JN (1991) Neurological manifestations of infection with the human immunodeficiency viruses. In: Scheld WM, Whitley RJ, Durack DT (eds) Infections of the central nervous system. Raven, New York, pp 201-232
30. Fotheringham J, Jacobson S (2005) Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease. Herpes 12:4-9
31. Fujinami RS (1996) Molecular mimicry. In: Shoenfeld Y, Peter JB (eds) Autoantibodies. Elsevier, Amsterdam, pp 507-519
32. Fujinami RS (1998) Molecular Mimicry. In: Rose NR, Mackay IR (eds) The autoimmune diseases. 3rd edn. Academic Press, San Diego, CA, pp 141-149
33. Fujinami RS (2000) Molecular mimicry and central nervous system autoimmune disease. In: Cunningham MW, Fujinami RS (eds) Molecular mimicry, microbes and autoimmunity, ASM, Washington, D C, pp 27-38
34. Fujinami RS (2001a) Can virus infections trigger autoimmune disease? J Autoimmun 16:229-234
35. Fujinami RS (2001b) Viruses and autoimmune disease-two sides of the same coin? Trends Microbiol 9:377-381
36. Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19:80-94
37. Gilden DH (2002) Multiple sclerosis exacerbations and infection. Lancet Neurol 1:145
38. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551-560
39. Granieri E, Casetta I, Tola MR, Ferrante P (2001) Multiple sclerosis: infectious hypothesis. Neurol Sci 22:179-185
40. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, de Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851-862
41. Holmoy T, Kvale EO, Vartdal F (2004) Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J NeuroVirol 10:278-283
42. Johnson RT (1998) Viral infections of the nervous system. Lippincott-Raven, Philadelphia Kantarci OH (2008) Genetics and natural history of multiple sclerosis. Semin Neurol 28:7-16
43. Kriesel JD, Sibley WA (2005) Editorial: the case for rhinoviruses in the pathogenesis of multiple sclerosis. Mult Scler 11:1-4
44. Kriesel JD, White A, Hayden FG, Spruance SL, Petajan J (2004) Multiple sclerosis attacks are associated with picornavirus infections. Mult Scler 10:145-148
45. Kurtzke JF (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6:382-427
46. Kurtzke JF (1997) The epidemiology of multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple sclerosis: clinical and pathogenetic basis. Chapman & Hall, London, pp 91-140
47. Kurtzke JF, Heltberg A (2001) Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol 54:1-22
48. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M (1966) Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatr 29:60-68
49. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A (2005) Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293:2496-2500
50. Libbey JE, Fujinami RS (2002) Are virus infections triggers for autoimmune disease? Clin Microbiol Newslett 24:73-76
51. Libbey JE, Fujinami RS (2003) Viral demyelinating disease in experimental animals. In: Herndon RM (ed) Multiple sclerosis: immunology, pathology and pathophysiology. Demos, New York, pp 125-133
52. Libbey JE, McCoy LL, Fujinami RS (2007) Molecular mimicry in multiple sclerosis. Int Rev Neurobiol 79:127-147
53. Liebert UG, Hashim GA, ter Meulen V (1990) Characterization of measles virus-induced cellular autoimmune reactions against myelin basic protein in Lewis rats. J Neuroimmunol 29:139-147
54. Lunemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, Munz C, Martin R (2006) Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129:1493-1506
55. Lunemann JD, Kamradt T, Martin R, Munz C (2007) Epstein-barr virus: environmental trigger of multiple sclerosis? J Virol 81:6777-6784
56. Lunemann JD, Munz C (2007) Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep 7:253-258
57. Maggi F, Fornai C, Vatteroni ML, Siciliano G, Menichetti F, Tascini C, Specter S, Pistello M, Bendinelli M (2001) Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders. J Med Virol 65:418-422
58. Marrie RA, Wolfson C, Sturkenboom MC, Gout O, Heinzlef O, Roullet E, Abenhaim L (2000) Multiple sclerosis and antecedent infections: a case-control study. Neurology 54:2307-2310
59. Massanari RM, Paterson PY, Lipton HL (1979) Potentiation of experimental allergic encephalomyelitis in hamsters with persistent encephalitis due to measles virus. J Infect Dis 139:297-303
60. McCoy L, Tsunoda I, Fujinami RS (2006) Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39:9-19
61. McElroy JP, Oksenberg JR (2008) Multiple sclerosis genetics. Curr Top Microbiol Immunol 318:45-72
62. Metz LM, McGuinness SD, Harris C (1998) Urinary tract infections may trigger relapse in multiple sclerosis. Axone 19:67-70
63. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3:1133-1136
64. Mokhtarian F, Swoveland P (1987) Predisposition to EAE induction in resistant mice by prior infection with Semliki forest virus. J Immunol 138:3264-3268
65. Niino M, Fukazawa T, Kikuchi S, Sasaki H (2007) Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications. Expert Rev Neurother 7:1175-1188
66. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD (2004) Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev 17:174-207
67. Oleszak EL, Leibowitz JL, Rodriguez M (1988) Isolation and characterization of two plaque size variants of Theiler's murine encephalomyelitis virus (DA strain). J Gen Virol 69(Pt 9):2413-2418
68. Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD (2001) A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 108:311-318
69. Panitch HS (1994) Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 36(Suppl):S25-S28
70. Patick AK, Oleszak EL, Leibowitz JL, Rodriguez M (1990) Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice. J Gen Virol 71:2123-2132
71. Pender MP, Greer JM (2007) Immunology of multiple sclerosis. Curr Allergy Asthma Rep 7:285-292
72. Peterson LK, Fujinami RS (2006) Molecular mimicry. In: Shoenfeld Y, Gershwin ME, Meroni P-L (eds) Autoantibodies, 2nd edn. Elsevier, Philadelphia, pp 13-20
73. Pohl D, Krone B, Rostasy K, Kahler E, Brunner E, Lehnert M, Wagner HJ, Gartner J, Hanefeld F (2006) High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67:2063-2065
74. Poskanzer DC, Schapira K, Miller H (1963a) Comparison of the epidemiology of multiple sclerosis and of poliomyelitis. Trans Am Neurol Assoc 88:253-255
75. Poskanzer DC, Schapira K, Miller H (1966) Multiple sclerosis and poliomyelitis. Acta Neurol Scand 42;Suppl 19:85-90
76. Poskanzer DC, Schapria K, Miller H (1963b) Multiple sclerosis and poliomyelitis. Lancet 2:917-921
77. Robertson NP, Clayton D, Fraser M, Deans J, Compston DA (1996) Clinical concordance in sibling pairs with multiple sclerosis. Neurology 47:347-352
78. Rutschmann OT, McCrory DC, Matchar DB (2002) Immunization and MS: a summary of published evidence and recommendations. Immunization Panel of the Multiple Sclerosis Council for Clinical Practice and Guidelines. Neurology 59:1837-1843
79. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899-2912
80. Sibley WA, Bamford CR, Clark K (1985) Clinical viral infections and multiple sclerosis. Lancet 1:1313-1315
81. Simmonds P (2002) TT virus infection: a novel virus-host relationship. J Med Microbiol 51:455-458
82. Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L, Seya T, McFarland HF, Jacobson S (2001) Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 50:486-493
83. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747
84. Sospedra M, Martin R (2006) Molecular mimicry in multiple sclerosis. Autoimmunity 39:3-8
85. Sospedra M, Zhao Y, Zur HH, Muraro PA, Hamashin C, de Villiers E-M, Pinilla C, Martin R (2005) Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog 1:e41
86. Tejada-Simon MV, Zang YCQ, Hong J, Rivera VM, Zhang JZ (2003) Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 53:189-197
87. Thacker EL, Mirzaei F, Ascherio A (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59:499-503
88. Theil DJ, Libbey JE, Rodriguez F, Whitton JL, Tsunoda I, Derfuss TJ, Fujinami RS. (2008) Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis. J Neuroimmunol 204:92-100
89. Theil DJ, Tsunoda I, Rodriguez F, Whitton JL, Fujinami RS (2001) Viruses can silently prime for and trigger central nervous system autoimmune disease. J NeuroVirol 7:220-227
90. Torkildsen O, Nyland H, Myrmel H, Myhr KM (2008) Epstein-Barr virus reactivation and multiple sclerosis. Eur J Neurol 15:106-108
91. Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55:673-686
92. Tsunoda I, Fujinami RS (2002) Inside-out versus Outside-in models for virus induced demyelination: axonal damage triggering demyelination. Springer Semin Immunopathol 24:105-125
93. Tsunoda I, Kuang L-Q, Libbey JE, Fujinami RS (2003) Axonal injury heralds virus-induced demyelination. Am J Pathol 162:1259-1269
94. Tsunoda I, Kuang L-Q, Tolley ND, Whitton JL, Fujinami RS (1998) Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol 57:758-767
95. Tsunoda I, Libbey JE, Fujinami RS (2007a) Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol 188:22-33
96. Tsunoda I, Tanaka T, Saijoh Y, Fujinami RS (2007b) Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol 171:1563-1575
97. Vandevelde M, Zurbriggen A (2005) Demyelination in canine distemper virus infection: a review. Acta Neuropathol 109:56-68
98. Virtanen JO, Farkkila M, Multanen J, Uotila L, Jaaskelainen AJ, Vaheri A, Koskiniemi M (2007) Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications. J Neurovirol 13:347-352
99. von Herrath MG, Fujinami RS, Whitton JL (2003) Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 1:151-157
100. Wandinger K, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner H, Wessel K, Kirchner H, Hennig H (2000) Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55:178-184
101. Wang L-Y, Fujinami RS (1997) Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol 75:75-83
102. Wang L-Y, Theil DJ, Whitton JL, Fujinami RS (1999) Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis. J Neuroimmunol 96:148-157
103. Whitley RJ, Schlitt M (1991) Encephalitis caused by herpesviruses, including B virus. In: Scheld WM, Whitley RJ, Durack DT (eds) Infections of the central nervous system. Raven, New York, pp 41-86
104. Whitton JL, Fujinami RS (1999) Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol 2:392-397